Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay
作者:Steve Arns、Jason Tan、Sharon Sun、Adam Galey、Natalia Zisman、Fiona Ross、Jenna Udechukwu、Samantha Dercho、Vionarica Gusti、Jay Paquette、Murray Webb、Elyse Bourque、Stephen G. Withers、Richard Liggins
DOI:10.1016/j.bmcl.2015.04.059
日期:2015.6
Difluorosialic acids (DFSAs) are potent inhibitors of viral neuraminidase that demonstrate activity against oseltamivir- and zanamivir-resistant strains of influenza. Unfortunately, low oral bioavailability precludes their development as second generation neuraminidase inhibitors for treating influenza as this leaves them unsuitable for use in an oral formulation. Herein is described the preparation of a series of DFSA prodrugs designed to increase oral bioavailability. These prodrugs were evaluated using a snapshot PK screen and stability tests, with successful candidates being further assessed with a full pharmacokinetic workup. These new prodrugs increased oral bioavailability by up to three times that seen for the parent DFSAs. (C) 2015 Elsevier Ltd. All rights reserved.